Tradestie Institutional Equity Comparison Engine

AQST vs HRMY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HRMY Overall Edge

HRMY Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harmony Biosciences Holdings, Inc. Common Stock (HRMY) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AQST trades at N/M Forward P/E with -114.1% operating margin (-41.0% YoY revenue) versus HRMY at 5.4x Forward P/E and 22.2% operating margin (+12.3% YoY). In options structure, AQST sits in BREAKDOWN (64th %ile IV; Dealer Gamma Walls on Pro) against HRMY sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner HRMY
AQST N/M vs HRMY 5.4x Fwd P/E
Growth & Margin Winner HRMY
Op Margin -114.1% vs 22.2% ยท YoY -41.0% vs +12.3%
Momentum & Technical Winner HRMY
1Y -40.6% vs -2.2% ยท 52W Pos 14% vs 38%
Options & Structure Winner HRMY
BREAKDOWN (64th %ile IV) vs CONSOLIDATION (11th %ile IV)
AQST NASDAQ
Aquestive Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$3.46
-6.61% 1D
Market Cap $465.7M
1M Return -16.22%
1Y Return -40.65%
Forward P/E N/M
Unified AI Score
62.9 / 100 BUY
Tech 54.0 Fund 68.0 Flow 68.0 Mom 60.0
HRMY NASDAQ
Harmony Biosciences Holdings, Inc. Common Stock
Pharmaceutical Preparations
$32.59
-1.18% 1D
Market Cap $1.9B
1M Return -9.55%
1Y Return -2.16%
Forward P/E 5.4x
Unified AI Score
67.1 / 100 BUY
Tech 80.0 Fund 74.0 Flow 70.0 Mom 70.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AQST -40.65% HRMY -2.16% Spread: +38.49 pp (HRMY Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AQST Revenue HRMY Revenue AQST Op. Margin HRMY Op. Margin Margin Edge
FY2018 $70M N/A -72.6% N/A AQST
FY2019 $50M $10M -100.1% -2433.8% AQST
FY2020 $50M $160M -93.6% 10.6% HRMY
FY2021 $50M $310M -68.2% 28.7% HRMY
FY2022 $50M $440M -88.2% 27.4% HRMY
FY2023 $50M $580M -29.9% 33.0% HRMY
FY2024 $60M $710M -53.5% 26.7% HRMY
FY2025 $40M $870M -159.5% 24.0% HRMY

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AQST (0) vs HRMY (10)
Institutional Metric AQST HRMY Criterion Row Winner
Market Capitalization Scale $465.7M $1.9B Larger Scale HRMY
Trailing P/E Ratio Valuation N/M 10.9x Lower Multiple HRMY
Forward P/E Ratio Valuation N/M 5.4x Lower Multiple HRMY
Revenue Growth (YoY) Growth -41.0% +12.3% Higher Growth HRMY
Operating Margin (TTM) Profitability -114.1% 22.2% Higher Margin HRMY
Net Profit Margin Profitability -162.3% 18.1% Higher Margin HRMY
Return on Equity (ROE) Capital Efficiency 0.0% 18.7% Higher ROE HRMY
52-Week Range Position Momentum 14% ($3โ€“$7) 38% ($26โ€“$43) Stronger Trend HRMY
Beta / 30D Volatility Risk Regime 0.89ฮฒ ยท 56% Vol 0.55ฮฒ ยท 38% Vol Lower Realized Risk HRMY
Unified Institutional Score Composite Signal 62.9 / 100 (BUY) 67.1 / 100 (BUY) Higher Composite HRMY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AQST vs HRMY Buy Guide
AQST BREAKDOWN
61d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 64th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live AQST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
HRMY CONSOLIDATION
114d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live HRMY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AQST nor HRMY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.